Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066 ...Middle East

PR Newswire - News
Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066
HOUSTON, Dec. 1, 2020 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that the US Food and Drug...

Hence then, the article about moleculin announces fda approves 3 rare pediatric disease designations for wp1066 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP1066 )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News